How many Rimegepant clinical trials are there?

50 Rimegepant clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 10 are actively recruiting participants. 24 are marked completed.

Are Rimegepant clinical trials recruiting in 2026?

Yes — 10 Rimegepant trials are actively recruiting in 2026, with 243 U.S. sites across 35 states. See the recruiting trials and the per-state site list further down this page.

What conditions is Rimegepant being studied for?

Rimegepant is being studied for Migraine, Migraine, With or Without Aura, Migraine With Aura, Migraine Without Aura, Acute Migraine and 29 more. The trials are grouped by indication on this page.

What phase is Rimegepant in?

Rimegepant clinical trials span 10 Phase 4, 15 Phase 3, 8 Phase 2. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.

Who sponsors Rimegepant clinical trials?

The lead sponsor across the most Rimegepant trials is Pfizer, with 18 additional lead sponsors listed in the data. Each trial row links to the full study detail page including sponsor information.

Rimegepant Clinical Trials (2026): 50 Studies for Migraine & Migraine, With or Without Aura

Creator: Hipa.ai Research
Published: 2026-05-08T19:37:22.397Z

Hipa.ai Research · Source: ClinicalTrials.gov / AACT

Synced daily from ClinicalTrials.gov via AACT. Last sync: June 12, 2026.

50 Rimegepant clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 22 indications (including Migraine & Migraine, With or Without Aura) and 33,538 total planned enrollment. 15 Phase 3 Rimegepant trials and 8 Phase 2, 10 Phase 4 are listed. 16 Rimegepant clinical trials are actively recruiting at 243 U.S. sites across 35 states. Most recent activity: NCT05156398 (Nov 2032).

Where to Participate: All Rimegepant Trial Sites in the U.S. (243 sites across 35 states)

Every actively recruiting Rimegepanttrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.

State	Facility	City	Trial	Map
AZ	Mayo Clinic Hospital	Phoenix85054	NCT06641466	Map
AZ	Mayo Clinic Specialty Building	Phoenix85054	NCT06641466	Map
AZ	Xenoscience Inc	Phoenix85004	NCT06616194	Map
AZ	Mayo Clinic Arizona	Scottsdale85259	NCT06641466	Map
AZ	Perseverance Research Center, LLC	Scottsdale85253	NCT04649242	Map
AZ	Perseverance Research Center, LLC	Scottsdale85253	NCT04743141	Map
CA	Advanced Research Center, Inc.	Anaheim92805	NCT04649242	Map
CA	Advanced Research Center, Inc.	Anaheim92805	NCT04743141	Map
CA	Hope Clinical Research, Inc.	Canoga Park91303	NCT06641466	Map
CA	Axiom Research	Colton92324	NCT06641466	Map
CA	Adult & Child Neurology Medical Associates	Costa Mesa92627	NCT04649242	Map
CA	Memorial Health Services	Fountain Valley92708	NCT04649242	Map
CA	Neuro-Pain Research Center	Fresno93710	NCT04649242	Map
CA	Neuro-Pain Research Center	Fresno93710	NCT04743141	Map
CA	Advanced Investigative Medicine, Inc.	Hawthorne90250	NCT05156398	Map
CA	Altman Clinical and Translational Research Institute, University of California San Diego	La Jolla93037	NCT04649242	Map
CA	Altman Clinical and Translational Research Institute, University of California San Diego	La Jolla93037	NCT04743141	Map
CA	Adult & Child Neurology Medical Associates	Long Beach90806	NCT04649242	Map
CA	Adult & Child Neurology Medical Associates	Long Beach90806	NCT04743141	Map
CA	Adult & Child Neurology Medical Associates	Long Beach90806	NCT06616194	Map
CA	Memorialcare Miller Children's & Women's Hospital Long Beach	Long Beach90806	NCT04743141	Map
CA	Miller Children's & Women's Hospital Long Beach	Long Beach90806	NCT04649242	Map
CA	The Neurology Group	Pomona91767	NCT04649242	Map
CA	The Neurology Group	Pomona91767	NCT04743141	Map
CA	Velocity Clinical Research- Banning	San Bernardino92408	NCT04743141	Map
CA	Velocity Clinical Research, San Bernardino (IP Delivery and Administering Location)	San Bernardino92408	NCT04649242	Map
CA	Diablo Clinical Research, Inc.	Walnut Creek94598	NCT06641466	Map
CA	Sunwise Clinical Research	Walnut Creek94596	NCT04649242	Map
CA	Sunwise Clinical Research	Walnut Creek94596	NCT04743141	Map
CO	Children's Hospital Colorado	Aurora80045	NCT04649242	Map
CO	Children's Hospital Colorado	Aurora80045	NCT04743141	Map
CO	Children's Hospital Colorado	Aurora80045	NCT06616194	Map
CO	Children's Hospital Colorado- Investigational Drug Services	Aurora80045	NCT04743141	Map
CO	Children's Hospital Colorado- lnvestigational Drug Services	Aurora80045	NCT04649242	Map
CT	CT Clinical Research	Cromwell06416	NCT04649242	Map
CT	CT Clinical Research	Cromwell06416	NCT04743141	Map
CT	Ki Health Partners, LLc, dba New England Institute for Clinical Research	Stamford06905	NCT04649242	Map
CT	Ki Health Partners, LLc, dba New England Institute for Clinical Research	Stamford06905	NCT04743141	Map
DC	Children's National Medical Center	Washington D.C.20010	NCT04649242	Map
DC	Children's National Medical Center	Washington D.C.20010	NCT04743141	Map
DC	Meridian Clinical Research, LLC	Washington D.C.20016	NCT05156398	Map
DC	Velocity Clinical Research, Washington DC	Washington D.C.20016	NCT05156398	Map
FL	VIN - Aventura	Aventura33180	NCT06641466	Map
FL	Velocity Clinical Research, Hallandale Beach	Hallandale33009	NCT06641466	Map
FL	Direct Helpers Research Center	Hialeah33012	NCT05156398	Map
FL	Jacksonville Center for Clinical Research	Jacksonville32216	NCT06641466	Map
FL	South Florida Research Phase I-IV, Inc	Miami33166	NCT04649242	Map
FL	South Florida Research Phase I-IV, Inc	Miami33166	NCT04743141	Map
FL	Aqualane Clinical Research	Naples34105	NCT04649242	Map
FL	Clinical Associates of Orlando, LLC	Orlando32819	NCT04649242	Map
FL	Clinical Associates of Orlando, LLC	Orlando32819	NCT04743141	Map
FL	D&H Tamarac Research Center LLC	Tamarac33321	NCT05156398	Map
FL	Santos Research Center, CORP	Tampa33615	NCT05156398	Map
GA	Children's Healthcare of Atlanta, Inc.	Atlanta30329	NCT04649242	Map
GA	Childrens Healthcare of Atlanta	Atlanta30329	NCT04649242	Map
GA	Childrens Healthcare of Atlanta	Atlanta30329	NCT04743141	Map
GA	Augusta University	Augusta30912	NCT05156398	Map
GA	Pivotal Clinical Research & Associates, LLC	Brunswick31520	NCT04649242	Map
GA	Pivotal Clinical Research & Associates, LLC	Brunswick31520	NCT04743141	Map
GA	CenExel iResearch, LLC	Decatur30030	NCT04649242	Map
GA	CenExel iResearch, LLC	Decatur30030	NCT04743141	Map
GA	Urban Family Practice Associates	Marietta30067	NCT06641466	Map
GA	Clinical Research Atlanta	Stockbridge30281	NCT06641466	Map
ID	Northwest Clinical Trials, Inc.	Boise83704	NCT05156398	Map
ID	St Luke's Clinic - Neurology	Meridian83642	NCT06641466	Map
IL	Ann & Robert H. Lurie Children's Hospital of Chicago	Chicago60611	NCT06616194	Map
IL	Chicago Headache Center & Research Institute	Chicago60657	NCT04649242	Map
IL	Chicago Headache Center & Research Institute	Chicago60657	NCT04743141	Map
IL	Chicago Headache Center and Research Institute	Chicago60657	NCT06616194	Map
IL	AMR-Baber Research Inc	Naperville60563	NCT04649242	Map
IL	AMR-Baber Research Inc	Naperville60563	NCT04743141	Map
IL	Chicago Headache Center and Research Institute	Naperville60563	NCT06616194	Map
IN	Alliance for Multispecialty Research - Medisphere Medical Research Center	Evansville47714	NCT06641466	Map
IN	Options Research Group, LLC	Westfield46074	NCT04649242	Map
IN	Options Research Group, LLC	Westfield46074	NCT04743141	Map
IA	Velocity Clinical Research, Sioux City	Sioux City51106	NCT04649242	Map
IA	Integrated Clinical Trial Services	West Des Moines50265	NCT04649242	Map
IA	Integrated Clinical Trial Services	West Des Moines50265	NCT04743141	Map
KS	Clinical Associates Midwest, LLC	Kansas City66214	NCT04649242	Map
KS	Clinical Associates Midwest, LLC	Kansas City66214	NCT04743141	Map
LA	Nola Research Works, LLC	New Orleans70125	NCT05156398	Map
MA	New England Regional Headache Center	Worcester01609	NCT06616194	Map
MI	Michigan Head Pain & Neurological Institute	Ann Arbor48104	NCT04649242	Map
MI	Michigan Head Pain and Neurological Institute	Ann Arbor48104	NCT04743141	Map
MI	Michigan Headache & Neurological Institute	Ann Arbor48104	NCT06616194	Map
MI	Michigan Headache & Neurological Institute	Ann Arbor48104	NCT06641466	Map
MI	Corewell Health, for and on behalf of Spectrum Health Hospital and Corewell Health Medical Group	Grand Rapids49503	NCT04649242	Map
MI	Corewell Health, for and on behalf of Spectrum Health Hospital and Corewell Health Medical Group	Grand Rapids49503	NCT04743141	Map
MI	Corewell Health, Helen DeVos Children's Hospital	Grand Rapids49503	NCT04649242	Map
MI	Corewell Health, Helen DeVos Children's Hospital	Grand Rapids49503	NCT04743141	Map
MI	Beaumont Hospital Royal Oak Campus	Royal Oak48073	NCT04649242	Map
MI	Beaumont Hospital, Royal Oak Campus	Royal Oak48073	NCT04743141	Map
MN	Brackenridge Outpatient Research Pharmacy	Rochester55905	NCT04649242	Map
MN	Clinical Research Trials Unit	Rochester55905	NCT04649242	Map
MN	Mayo Clinic	Rochester55905	NCT04649242	Map
MS	Safe Haven Clinical Research	Clinton39056	NCT05156398	Map
MS	Precise Research Centers	Flowood39232	NCT04649242	Map
MO	Roy Blunt NextGen Precision Health Building	Columbia65211	NCT05156398	Map
MO	University of Missouri	Columbia65212	NCT05156398	Map
MO	University of Missouri Health Care - Investigation Pharmacy	Columbia65212	NCT05156398	Map
MO	University of Missouri-Clinical and Translational Sciences Unit	Columbia65212	NCT05156398	Map
MO	Clinvest Headlands Llc	Springfield65807	NCT06616194	Map
MO	Clinvest Headlands Llc	Springfield65807	NCT06641466	Map
MO	St. Charles Clinical Research	Weldon Spring63304	NCT06641466	Map
MT	Boeson Research	Great Falls59405	NCT04649242	Map
MT	Boeson Research	Great Falls59405	NCT04743141	Map
MT	Blue Moose Pediatrics	Missoula59804	NCT04649242	Map
MT	Blue Moose Pediatrics	Missoula59804	NCT04743141	Map
MT	Boeson Research	Missoula59804	NCT04649242	Map
MT	Boeson Research	Missoula59804	NCT04743141	Map
MT	Boeson Research Laboratory	Missoula59804	NCT04649242	Map
MT	Boeson Research Laboratory	Missoula59804	NCT04743141	Map
NE	Velocity Clinical Research, Grand Island	Grand Island68803	NCT05156398	Map
NE	Children's Hospital & Medical Center	Omaha68114	NCT04649242	Map
NE	Children's Hospital & Medical Center	Omaha68114	NCT04743141	Map
NE	McGill Family Practice	Papillion68046	NCT06641466	Map
NE	Papillion Research Center/CCT Research	Papillion68046	NCT05156398	Map
NV	Excel Clinical Research, LLC	Las Vegas89109	NCT06641466	Map
NJ	HMH Jersey Shore University Medical Center	Neptune City07753	NCT04649242	Map
NJ	HOPE Tower at Jersey Shore University Medical Center	Neptune City07753	NCT04649242	Map
NJ	Rutgers University	New Brunswick08901	NCT06616194	Map
NY	Dent Neurosciences Research Center	Amherst14226	NCT04649242	Map
NY	Dent Neurosciences Research Center	Amherst14226	NCT04743141	Map
NY	Maimonides Medical Center	Brooklyn11219	NCT06473597	Map
NY	True North Neurology	Commack11725	NCT04649242	Map
NY	True North Neurology	Commack11725	NCT04743141	Map
NY	Northwell Health/ Division of Pediatric Neurology	Lake Success11042	NCT04649242	Map
NY	New York Neurology Associates	New York10003	NCT04649242	Map
NY	New York Neurology Associates	New York10003	NCT04743141	Map
NY	Weill Cornell Medicine	New York10021	NCT04649242	Map
NY	Rochester Clinical Research	Rochester14609	NCT06641466	Map
NY	Montefiore Medical Center	The Bronx10461	NCT05156398	Map
NY	Montefiore Medical Center	The Bronx10461	NCT06641466	Map
NC	OnSite Clinical Solutions	Charlotte28211	NCT06616194	Map
NC	OnSite Clinical Solutions, LLC	Charlotte28277	NCT04649242	Map
NC	OnSite Clinical Solutions, LLC	Charlotte28277	NCT04743141	Map
NC	Carolina Women's Research and Wellness Center	Durham27713	NCT06641466	Map
NC	Duke Children's Health Center	Durham27710	NCT06616194	Map
NC	Duke Health Center Creekstone	Durham27703	NCT06616194	Map
NC	Duke Lenox Baker Children's	Durham27705	NCT06616194	Map
NC	Velocity Clinical Research, Inc.	Durham27701	NCT04649242	Map
NC	Headache Wellness Center, PC	Greensboro27405	NCT04649242	Map
NC	Headache Wellness Center, PC	Greensboro27405	NCT04743141	Map
OH	Dayton Center for Neurological Disorders	Centerville45459	NCT06641466	Map
OH	Cincinnati Children's Hospital	Cincinnati45229	NCT04743141	Map
OH	Cincinnati Children's Hospital Medical Center	Cincinnati45229	NCT04649242	Map
OH	Cincinnati Children's Hospital Medical Center	Cincinnati45229	NCT05156398	Map
OH	Cincinnati Children's Hospital Medical Center	Cincinnati45229	NCT06616194	Map
OH	Velocity Clinical Research	Cincinnati45242	NCT04649242	Map
OH	Velocity Clinical Research - Cincinnati	Cincinnati45242	NCT04743141	Map
OH	Cleveland Clinic	Cleveland44195	NCT06616194	Map
OH	University Hospitals Cleveland Medical Center	Cleveland44106	NCT04649242	Map
OH	University Hospitals Cleveland Medical Center	Cleveland44106	NCT04743141	Map
OR	Providence Neuroscience Institute - Research Coordinator's Office	Portland97225	NCT04649242	Map
OR	Providence Neuroscience Institute: Research Coordinators' Office	Portland97225	NCT04743141	Map
OR	Providence Pediatric Specialty Clinic	Portland97225	NCT04743141	Map
OR	Providence St. Vincent Medical Center	Portland97225	NCT04649242	Map
PA	Clario	Philadelphia19103	NCT04649242	Map
PA	Clinical Research of Philadelphia	Philadelphia19114	NCT06641466	Map
PA	Thomas Jefferson University, Jefferson Headache Center	Philadelphia19107	NCT06641466	Map
PA	UPMC Children's Hospital of Pittsburgh	Pittsburgh15224	NCT06616194	Map
RI	Velocity Clinical Research-Providence	East Greenwich02818	NCT04649242	Map
RI	Velocity Clinical Research-Providence	East Greenwich02818	NCT04743141	Map
RI	Velocity Clinical Research, Providence	East Greenwich02818	NCT06641466	Map
SD	Avera McKennan Hospital & University Health Center	Sioux Falls57105	NCT05156398	Map
SD	Avera Medical Group Pediatric Specialists	Sioux Falls57105	NCT06616194	Map
SD	Avera Medical Group Pediatrics - Dawley Farm	Sioux Falls57110	NCT05156398	Map
SD	Avera Medical Group Pediatrics - Dawley Farm	Sioux Falls57110	NCT06616194	Map
SD	Avera Research Institute	Sioux Falls57108	NCT05156398	Map
SD	Avera Research Institute - Sioux Falls	Sioux Falls57108	NCT06616194	Map
TN	Alliance for Multispecialty Research, LLC	Knoxville37909	NCT06641466	Map
TN	Alliance for Multispecialty Research, LLC	Knoxville37920	NCT06641466	Map
TN	AMR Clinical	Knoxville37909	NCT06641466	Map
TN	Le Bonheur Children's Hospital	Memphis38103	NCT04649242	Map
TN	Le Bonheur Children's Hospital	Memphis38103	NCT04743141	Map
TN	Le Bonheur Children's Hospital - Outpatient Building	Memphis38103	NCT04649242	Map
TN	Le Bonheur Childrens Hospital - Childrens Foundation Research Institute	Memphis38103	NCT04649242	Map
TN	Le Bonheur Childrens Hospital - Childrens Foundation Research Institute	Memphis38103	NCT04743141	Map
TN	Le Bonheur Childrens Hospital - Outpatient Building	Memphis38103	NCT04743141	Map
TX	Child Neurology Consultants of Austin - Central Austin	Austin78757	NCT04649242	Map
TX	Child Neurology Consultants of Austin - Central Austin	Austin78757	NCT04743141	Map
TX	Child Neurology Consultants of Austin - South Austin	Austin78749	NCT04649242	Map
TX	Child Neurology Consultants of Austin - South Austin	Austin78749	NCT04743141	Map
TX	Dell Children's Medical Center	Austin78723	NCT04649242	Map
TX	Dell Children's Medical Center	Austin78723	NCT04743141	Map
TX	Dell Children's Medical Center	Austin78723	NCT06616194	Map
TX	FutureSearch Trials of Neurology	Austin78731	NCT06641466	Map
TX	Houston Clinical Trials, LLC	Bellaire77401	NCT04649242	Map
TX	Houston Clinical Trials, LLC	Bellaire77401	NCT04743141	Map
TX	Alina Clinical Trials, LLC.	Dallas75209	NCT05156398	Map
TX	FutureSearch Trials of Dallas	Dallas75251	NCT06641466	Map
TX	FutureSearch Trials of Dallas, LLC	Dallas75251	NCT04649242	Map
TX	ANESC Research	El Paso79912	NCT04649242	Map
TX	ANESC Research	El Paso79912	NCT04743141	Map
TX	Headlands Research-El Paso	El Paso79902	NCT06616194	Map
TX	North Texas Center for Clinical Research	Frisco75034	NCT05156398	Map
TX	DM Clinical Research - Cy Fair	Houston77065	NCT05156398	Map
TX	NeuroCare Plus	Houston77094	NCT04649242	Map
TX	NeuroCare Plus	Houston77094	NCT04743141	Map
TX	NeuroCare Plus	Houston77094	NCT05156398	Map
TX	Pain and Headache Centers of Texas	Houston77054	NCT04649242	Map
TX	Pain and Headache Centers of Texas	Houston77054	NCT04743141	Map
TX	SCLA Management	Houston77077	NCT04649242	Map
TX	SCLA Management	Houston77077	NCT04743141	Map
TX	SCLA Management - Drop Box	Houston77077	NCT05156398	Map
TX	SCLA Management Office	Houston77077	NCT05156398	Map
TX	The University of Texas Health Science Center at Houston	Houston77030	NCT06616194	Map
TX	UTHealth Houston	Houston77030	NCT04649242	Map
TX	DCT-McAllen Primary Care Research, LLC dba Discovery Clinical Trials	McAllen78503	NCT05156398	Map
TX	AIM Trials, LLC	Plano75093	NCT04649242	Map
TX	AIM Trials, LLC	Plano75093	NCT04743141	Map
TX	DCT-Stone Oak, LLC dba Discovery Clinical Trials	San Antonio78258	NCT05156398	Map
TX	DM Clinical Research (Administrative Office Only)	Tomball77375	NCT05156398	Map
UT	Granger Medical Holladay - Holladay Clinic	Salt Lake City84117	NCT06616194	Map
UT	JBR Clinical Research	Salt Lake City84107	NCT04649242	Map
UT	JBR Clinical Research	Salt Lake City84107	NCT04743141	Map
UT	Wasatch Clinical Research , LLC(Administrative Location)	Salt Lake City84107	NCT04649242	Map
UT	Wasatch Clinical Research , LLC(Administrative Location)	Salt Lake City84107	NCT04743141	Map
UT	Wasatch Clinical Research, LLC	Salt Lake City84107	NCT06616194	Map
VA	Charlottesville Medical Research	Charlottesville22911	NCT06641466	Map
VA	Pediatric Associates of Charlottesville, PLC (Private Pediatric Practice)	Charlottesville22902	NCT04649242	Map
VA	Pediatric Associates of Charlottesville, PLC (Private Pediatric Practice)	Charlottesville22902	NCT04743141	Map
VA	Pediatric Research of Charlottesville, LLC	Charlottesville22902	NCT04649242	Map
VA	Pediatric Research of Charlottesville, LLC	Charlottesville22902	NCT04743141	Map
VA	Pediatric Research of Charlottesville, LLC (Regulatory Only)	Charlottesville22902	NCT04649242	Map
VA	Pediatric Research of Charlottesville, LLC (Regulatory Only)	Charlottesville22902	NCT04743141	Map
VA	MedStar Health Neurology/MedStar Georgetown Headache Center	McLean22101	NCT06641466	Map
VA	MedStar Health: Neurology at McLean	McLean22101	NCT07301008	Map
VA	Children's Hospital of the King's Daughters	Norfolk23507	NCT04649242	Map
VA	Children's Hospital of The King's Daughters	Norfolk23507	NCT04743141	Map
VA	Children's Specialty Group, PLLC	Norfolk23507	NCT04649242	Map
VA	Children's Specialty Group, PLLC , Division of Childhood & Adolescent Neurology	Norfolk23510	NCT04743141	Map
VA	Children's Specialty Group, PLLC, Division of Childhood & Adolescent Neurology	Norfolk23510	NCT04649242	Map
WA	Northwest Clinical Research Center	Bellevue98007	NCT04649242	Map
WA	Northwest Clinical Research Center	Bellevue98007	NCT04743141	Map
WA	Seattle Children's Hospital	Seattle98105	NCT04649242	Map
WA	Seattle Children's Hospital	Seattle98105	NCT04743141	Map
WA	Seattle Children's Hospital	Seattle98105	NCT06616194	Map
WA	Seattle Children's Hospital Investigational Drug Services	Seattle98105	NCT04649242	Map
WA	Seattle Children's Hospital Investigational Drug Services	Seattle98105	NCT04743141	Map
WI	Clinical Investigation Specialists, Inc	Kenosha53144	NCT04649242	Map
WI	University Hospital	Madison53792	NCT04649242	Map
WI	University Hospital	Madison53792	NCT04743141	Map

Rimegepant clinical trials at a glance: phase × recruitment status

Phase	recruiting	active not recruiting	enrolling by invitation	completed	terminated	not yet recruiting	unknown	no longer available	Total
P1/P2						1			1
P2		1		4	1	2			8
P2/P3				2		1			3
P3	5			9	1				15
P4	2			6	2				10
N/A	2	3	1	3		2	1	1	13

Recruiting Rimegepant clinical trials (16)

Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).

NCT ID	Title	Phase	Indication	Enrollment	Started
NCT05156398	Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects	P3	Migraine	640	Feb 2022
NCT07497854	Rimegepant PMSA Study to Learn About the Study Medicine NURTEC® ODT 75 mg After it is Released Into the Markets in Korea	—	Migraine With or Without Aura	3,000	Oct 2026
NCT04743141	Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine	P3	Acute Treatment of Migraine	600	Apr 2021
NCT06999252	Rimegepant Combined With PD-1 in Liver Metastasis Colorectal Cancer Patients	P2	Colon Cancer	20	Jul 2025
NCT04649242	Randomized Study in Children and Adolescents With Migraine: Acute Treatment	P3	Pediatric Migraine	2,100	Jan 2021
NCT07475234	RAG-MPDACRimegepant Combined With AG Chemotherapy As First-Line Treatment For Metastatic Pancreatic Ductal Adenocarcinoma	P1/P2	Metastatic Pancreatic Ductal Adenocarcinoma	30	Mar 2026
NCT07435090	Efficacy and Safety of Rimegepant for Acute Dizziness	P2/P3	Dizziness	370	Mar 2026
NCT06728345	The Real-world Study of Rimegepant Treatment in Female Migraine Patients of China	—	Migraine	300	Dec 2024
NCT06616194	A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine	P3	Migraine	200	Nov 2024
NCT06409832	RAISERimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment	—	Migraine	100	Mar 2024
NCT06748664	A Clinical Trial of Rimegepant for Vestibular Migraine Evaluation: Pre-experiment	P2	Vestibular Migraine	240	Jun 2025
NCT06641466	A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine	P3	Menstrual Migraine	723	Mar 2025
NCT07301008	RIMRimegepant as Preemptive Treatment for Predictable Trigger-Induced Migraine in Adult Patients in the US	P4	Migraine	60	Sep 2025
NCT06473597	A Comparison of Nurtec ODT to Maxalt MLT-ODT in Adult ED Patients With Migraine Headache	P4	Migraine	80	Sep 2024
NCT06212661	Migraine Medication Effects on Urinary Symptoms	—	Overactive Bladder	200	Apr 2024
NCT05903027	GAINERGepant treAtments: EffectIveNess and tolERability (GAINER)	—	Migraine	100	Jun 2023

Rimegepant clinical trials by indication

Migraine (24)

NCT	Acronym	Phase	Status	Title
NCT05156398	—	P3	recruiting	Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
NCT05198245	—	N/A	active not recruiting	Study of Pregnancy Outcomes in Women Exposed to Rimegepant During Pregnancy
NCT06728345	—	N/A	not yet recruiting	The Real-world Study of Rimegepant Treatment in Female Migraine Patients of China
NCT06616194	—	P3	recruiting	A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine
NCT06409832	RAISE	N/A	recruiting	RimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment
NCT06439628	—	N/A	active not recruiting	ARISE-A Chinese Real-world Study of Rimegepant for the Acute Treatment of Migraine
NCT07301008	RIM	P4	recruiting	Rimegepant as Preemptive Treatment for Predictable Trigger-Induced Migraine in Adult Patients in the US
NCT06473597	—	P4	recruiting	A Comparison of Nurtec ODT to Maxalt MLT-ODT in Adult ED Patients With Migraine Headache
+ 16 more, see All trials below.

Migraine, With or Without Aura (4)

NCT	Acronym	Phase	Status	Title
NCT03266588	—	P2/P3	completed	Open Label Safety Study in Acute Treatment of Migraine
NCT03461757	—	P3	completed	Trial in Adult Subjects With Acute Migraines
NCT03237845	—	P3	completed	Safety and Efficacy in Adult Subjects With Acute Migraines
NCT03235479	—	P3	completed	Safety and Efficacy Study in Adult Subjects With Acute Migraines

Vestibular Migraine (2)

NCT	Acronym	Phase	Status	Title
NCT06748664	—	P2	not yet recruiting	A Clinical Trial of Rimegepant for Vestibular Migraine Evaluation: Pre-experiment
NCT06992674	—	P2	active not recruiting	The R-E-V-I-V-A-L Study

Acute Migraine (2)

NCT	Acronym	Phase	Status	Title
NCT05371652	—	P3	completed	A Study to Learn About the Long-term Safety of Rimegepant for the Acute Treatment of Migraine in Chinese Participants
NCT04574362	—	P3	completed	Safety and Efficacy Trial of BHV3000 (Rimegepant) 75 mg for the Acute Treatment of Migraine

Migraine With or Without Aura (1)

NCT	Acronym	Phase	Status	Title
NCT07497854	Rimegepant PMS	N/A	not yet recruiting	A Study to Learn About the Study Medicine NURTEC® ODT 75 mg After it is Released Into the Markets in Korea

Metastatic Pancreatic Ductal Adenocarcinoma (1)

NCT	Acronym	Phase	Status	Title
NCT07475234	RAG-MPDAC	P1/P2	not yet recruiting	Rimegepant Combined With AG Chemotherapy As First-Line Treatment For Metastatic Pancreatic Ductal Adenocarcinoma

Dizziness (1)

NCT	Acronym	Phase	Status	Title
NCT07435090	—	P2/P3	not yet recruiting	Efficacy and Safety of Rimegepant for Acute Dizziness

Colon Cancer (1)

NCT	Acronym	Phase	Status	Title
NCT06999252	—	P2	not yet recruiting	Rimegepant Combined With PD-1 in Liver Metastasis Colorectal Cancer Patients

Migraine Headaches (1)

NCT	Acronym	Phase	Status	Title
NCT06985342	—	P4	terminated	Acute Migraine Treatment in the ED With Gepants

Menstrual Migraine (1)

NCT	Acronym	Phase	Status	Title
NCT06641466	—	P3	recruiting	A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

Irritable Bowel Syndrome (1)

NCT	Acronym	Phase	Status	Title
NCT06221111	—	P2	completed	Comparison of Rimegepant and Placebo for Pain in IBS

Overactive Bladder (1)

NCT	Acronym	Phase	Status	Title
NCT06212661	—	N/A	enrolling by invitation	Migraine Medication Effects on Urinary Symptoms

Migraine Disorders (1)

NCT	Acronym	Phase	Status	Title
NCT05888766	—	N/A	unknown	Predict the Response to Acute Treatment of Migraine With Rimegepant 75 mg

Cluster Headache (1)

NCT	Acronym	Phase	Status	Title
NCT05264714	—	P2	completed	Cluster Headache Treatment With Rimegepant

Migraine With Aura (1)

NCT	Acronym	Phase	Status	Title
NCT05211154	ATOM	P4	terminated	Evaluation of the Efficacy of Diclofenac Potassium and Rimegepant for the Acute Treatment of Migraine

Temporomandibular Disorders (TMD) (1)

NCT	Acronym	Phase	Status	Title
NCT05262517	—	P3	terminated	Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for Acute Treatment of Temporomandibular Disorders

Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps (1)

NCT	Acronym	Phase	Status	Title
NCT05248997	—	P3	completed	Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for the Acute Treatment of Chronic Rhinosinusitis

Acute Treatment of Migraine (1)

NCT	Acronym	Phase	Status	Title
NCT04743141	—	P3	recruiting	Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

Pain (1)

NCT	Acronym	Phase	Status	Title
NCT04860713	—	P4	completed	An Efficacy and Safety of Proprietary Formulations of Oral Ketamine + Aspirin in Treatment of Acute Headache

Psoriasis (1)

NCT	Acronym	Phase	Status	Title
NCT04629950	—	P2	completed	Rimegepant in Moderate Plaque-type Psoriasis

Pediatric Migraine (1)

NCT	Acronym	Phase	Status	Title
NCT04649242	—	P3	recruiting	Randomized Study in Children and Adolescents With Migraine: Acute Treatment

Trigeminal Neuralgia (1)

NCT	Acronym	Phase	Status	Title
NCT03941834	—	P2	terminated	Trial for Treatment Refractory Trigeminal Neuralgia

Rimegepant pivotal trial highlights (Phase 2/3/4)

Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.

Acronym	NCT	Phase	Status	Indication	Enrollment	PubMed
RIM	NCT07301008	P4	recruiting	Migraine	60	—
ATOM	NCT05211154	P4	terminated	Migraine With Aura	300	—
CHALLENGE-MIG	NCT05127486	P4	completed	Migraine	580	PMID 37948006
BMS-927711	NCT01430442	P2	completed	Migraine	1,026	PMID 23965396

Terminated and withdrawn Rimegepant trials (4)

Studies that ended before completion. Reasons are filed in each trial's ClinicalTrials.gov entry.

NCT06985342terminatedAcute Migraine Treatment in the ED With Gepants
NCT05211154terminatedEvaluation of the Efficacy of Diclofenac Potassium and Rimegepant for the Acute Treatment of Migraine
NCT05262517terminatedSafety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for Acute Treatment of Temporomandibular Disorders
NCT03941834terminatedTrial for Treatment Refractory Trigeminal Neuralgia

All Rimegepant trials (50)

Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.

NCT ID	Acronym	Title	Phase	Status	Enrollment	Sponsor	Started
NCT05156398		Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects	P3	recruiting	640	Pfizer	Feb 2022
NCT07497854	Rimegepant PMS	A Study to Learn About the Study Medicine NURTEC® ODT 75 mg After it is Released Into the Markets in Korea	—	not yet recruiting	3,000	Pfizer	Oct 2026
NCT04743141		Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine	P3	recruiting	600	Pfizer	Apr 2021
NCT06999252		Rimegepant Combined With PD-1 in Liver Metastasis Colorectal Cancer Patients	P2	not yet recruiting	20	Fudan University	Jul 2025
NCT04649242		Randomized Study in Children and Adolescents With Migraine: Acute Treatment	P3	recruiting	2,100	Pfizer	Jan 2021
NCT07475234	RAG-MPDAC	Rimegepant Combined With AG Chemotherapy As First-Line Treatment For Metastatic Pancreatic Ductal Adenocarcinoma	P1/P2	not yet recruiting	30	Xiuchao Wang	Mar 2026
NCT07435090		Efficacy and Safety of Rimegepant for Acute Dizziness	P2/P3	not yet recruiting	370	Shi Tianming	Mar 2026
NCT05198245		Study of Pregnancy Outcomes in Women Exposed to Rimegepant During Pregnancy	—	active not recruiting	1	Pfizer	Dec 2021
NCT06728345		The Real-world Study of Rimegepant Treatment in Female Migraine Patients of China	—	not yet recruiting	300	The First Affiliated Hospital of Soochow University	Dec 2024
NCT06616194		A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine	P3	recruiting	200	Pfizer	Nov 2024
NCT06409832	RAISE	RimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment	—	recruiting	100	University of Florence	Mar 2024
NCT06439628		ARISE-A Chinese Real-world Study of Rimegepant for the Acute Treatment of Migraine	—	active not recruiting	3,000	Chinese PLA General Hospital	Aug 2024
NCT06748664		A Clinical Trial of Rimegepant for Vestibular Migraine Evaluation: Pre-experiment	P2	not yet recruiting	240	Second Affiliated Hospital, School of Medicine, Zhejiang University	Jun 2025
NCT06641466		A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine	P3	recruiting	723	Pfizer	Mar 2025
NCT07301008	RIM	Rimegepant as Preemptive Treatment for Predictable Trigger-Induced Migraine in Adult Patients in the US	P4	recruiting	60	Medstar Health Research Institute	Sep 2025
NCT06473597		A Comparison of Nurtec ODT to Maxalt MLT-ODT in Adult ED Patients With Migraine Headache	P4	recruiting	80	Antonios Likourezos	Sep 2024
NCT06212661		Migraine Medication Effects on Urinary Symptoms	—	enrolling by invitation	200	The Cleveland Clinic	Apr 2024
NCT06992674		The R-E-V-I-V-A-L Study	P2	active not recruiting	240	Second Affiliated Hospital, School of Medicine, Zhejiang University	Jun 2025
NCT05903027	GAINER	Gepant treAtments: EffectIveNess and tolERability (GAINER)	—	recruiting	100	University of Florence	Jun 2023
NCT06898047	CORRELATE-UK	Consistency of Response With Rimegepant in Acute Treatment of Migraine	—	active not recruiting	250	Pfizer	Nov 2025
NCT06985342		Acute Migraine Treatment in the ED With Gepants	P4	terminated	9	Icahn School of Medicine at Mount Sinai	Jun 2025
NCT05264714		Cluster Headache Treatment With Rimegepant	P2	completed	20	Mayo Clinic	Sep 2022
NCT05810038		A Study to Learn About the Safety and Effects of Rimegepant to Prevent Migraine in Chinese Subjects.	P3	completed	787	Pfizer	May 2023
NCT05518123		Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications	P4	completed	962	Pfizer	Nov 2022
NCT05509400		Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use	P4	completed	813	Pfizer	Oct 2022
NCT06221111		Comparison of Rimegepant and Placebo for Pain in IBS	P2	completed	39	Mayo Clinic	Jun 2024
NCT05211154	ATOM	Evaluation of the Efficacy of Diclofenac Potassium and Rimegepant for the Acute Treatment of Migraine	P4	terminated	300	Danish Headache Center	May 2022
NCT05709106		A Prospective Real World Study of Rimegepant in the Treatment of Migraine	—	completed	173	Ruijin-Hainan Hospital Shanghai Jiao Tong University School Of Medicine	Jan 2023
NCT05217927		Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens	P4	completed	1,415	Pfizer	Mar 2022
NCT06680206		Comparison of Patient-reported Outcomes for Rimegepant and Triptans in the 2023 US National Health and Wellness Survey	—	completed	1,395	Pfizer	Oct 2024
NCT04629950		Rimegepant in Moderate Plaque-type Psoriasis	P2	completed	41	Weill Medical College of Cornell University	Jan 2021
NCT05399485		Efficacy and Safety Study of Rimegepant for Migraine Prevention in Japanese Subjects (Japan Only)	P3	completed	496	Pfizer	Aug 2022
NCT05888766		Predict the Response to Acute Treatment of Migraine With Rimegepant 75 mg	—	unknown	20	University of Roma La Sapienza	Jul 2023
NCT05207865		Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention	P4	completed	441	Pfizer	Mar 2022
NCT06221267		A Registry Study on Rimegepant for the Treatment of Migraine Participants in Guangdong-Hong Kong-Macao Greater Bay Area	—	completed	120	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	Jan 2024
NCT05248997		Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for the Acute Treatment of Chronic Rhinosinusitis	P3	completed	261	Pfizer	Feb 2022
NCT05371652		A Study to Learn About the Long-term Safety of Rimegepant for the Acute Treatment of Migraine in Chinese Participants	P3	completed	241	Pfizer	May 2022
NCT05399459		Efficacy and Safety Study of Rimegepant for the Acute Treatment of Migraine in Japanese Subjects (Japan Only)	P3	completed	897	Pfizer	Aug 2022
NCT05127486	CHALLENGE-MIG	A Study of Galcanezumab (LY2951742) in Adult Participants With Episodic Migraine	P4	completed	580	Eli Lilly and Company	Dec 2021
NCT05262517		Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for Acute Treatment of Temporomandibular Disorders	P3	terminated	126	Pfizer	May 2022
NCT03941834		Trial for Treatment Refractory Trigeminal Neuralgia	P2	terminated	65	Pfizer	Jun 2019
NCT04860713		An Efficacy and Safety of Proprietary Formulations of Oral Ketamine + Aspirin in Treatment of Acute Headache	P4	completed	5	Antonios Likourezos	Apr 2021
NCT04574362		Safety and Efficacy Trial of BHV3000 (Rimegepant) 75 mg for the Acute Treatment of Migraine	P3	completed	1,648	Pfizer	Oct 2020
NCT03732638		Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults	P2/P3	completed	1,590	Pfizer	Nov 2018
NCT03266588		Open Label Safety Study in Acute Treatment of Migraine	P2/P3	completed	3,019	Pfizer	Aug 2017
NCT03934086		An Open-label, Intermediate Size, Expanded Access Study of BHV-3000 in the Acute Treatment of Migraine	—	no longer available	0	Pfizer	—
NCT03461757		Trial in Adult Subjects With Acute Migraines	P3	completed	1,811	Pfizer	Feb 2018
NCT03237845		Safety and Efficacy in Adult Subjects With Acute Migraines	P3	completed	1,499	Pfizer	Jul 2017
NCT03235479		Safety and Efficacy Study in Adult Subjects With Acute Migraines	P3	completed	1,485	Pfizer	Jul 2017
NCT01430442	BMS-927711	Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine	P2	completed	1,026	Pfizer	Oct 2011

Rimegepant clinical trials: frequently asked questions

How many Rimegepant clinical trials are there?: 50 Rimegepant clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 10 are actively recruiting participants. 24 are marked completed.
Are Rimegepant clinical trials recruiting in 2026?: Yes — 10 Rimegepant trials are actively recruiting in 2026, with 243 U.S. sites across 35 states. See the recruiting trials and the per-state site list further down this page.
What conditions is Rimegepant being studied for?: Rimegepant is being studied for Migraine, Migraine, With or Without Aura, Migraine With Aura, Migraine Without Aura, Acute Migraine and 29 more. The trials are grouped by indication on this page.
What phase is Rimegepant in?: Rimegepant clinical trials span 10 Phase 4, 15 Phase 3, 8 Phase 2. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
Who sponsors Rimegepant clinical trials?: The lead sponsor across the most Rimegepant trials is Pfizer, with 18 additional lead sponsors listed in the data. Each trial row links to the full study detail page including sponsor information.

Sources and methodology

Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Rimegepantas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.

Last refreshed June 12, 2026.

Related pages on Hipa.ai:

Rimegepant overview Rimegepant evidence & publications